Skip to content

HIV treatment is costly, especially for the sickest patients

Image: Africa Studio/Shutterstock.com

High long-term economic costs associated with late HIV diagnosis

US CDC finds 19 percent HIV prevalence among MSM in 21-city survey

FTC therapy reduces risk of important resistance mutation

Early warning indicators for drug resistance in resource-limited settings piloted in Namibia

Darunavir/ritonavir as effective in women as men

Higher HIV rates among black MSM in the US may be linked to attitudes about homosexuality

Majority of US gay men support HIV transmission laws

Longer viral load is undetectable, lower the risk of rebound